Last updated on September 2018

A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of molidustat in non-dialysis subjects with renal anemia who are not treated with Erythropoiesis-Stimulating Agents (ESAs).

Clinical Study Identifier: NCT03350321

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

JCHO Yokkaichi Hazu Medical Center
Yokkaichi, Japan